J.-R. Claude (France): Safety pharmacology in the non clinical assessment of new medicinal products: installé, interest and difficulties.
K. Olejniczak (Germany): The ICH remarque for guidance.
P. Spindler (Denmark): The GLP requirements in safety pharmacology.
C. Rochat (France): Strategy for safety pharmacology studies in the alternance of the clinical development.
G. Bode (Germany): Safety pharmacology studies in the alternance of toxicology studies.